Shows / touchPODCAST
touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy…
Episodes
- touchPODCAST
Initial assessment of NSCLC
touchMDT for touchONCOLOGY Listen to a medical oncologist and a radiation oncologist discuss the importance of the initial assessment in NSCLC and the role of…
- touchPODCAST
Experts discuss the emerging role of SERDs in HR+ breast cancer
touchPANEL DISCUSSION for touchONCOLOGY Listen to leading experts review the latest advances in HR+ breast cancer, focusing on the management of specific…
- touchPODCAST
Novel targeted therapies for NSCLC: Exploring HER2 dysregulation
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of experts discuss the latest clinical research in HER2 dysregulation and potential HER2-targeted…
- touchPODCAST
Experts discuss non-steroidal MRAs for the treatment of patients with T2D and CKD
touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to leading experts discuss why the treatment landscape for patients with T2D and CKD requires novel…
- touchPODCAST
Immunotherapy and evolving approaches for basal cell carcinoma
touchPANEL DISCUSSION for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with EGFR-mutant NSCLC, and the rationale for…
- touchPODCAST
MDT and patient perspectives on antihyperglycemic therapies and their association with weight loss
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the importance of weight loss in T2D; GLP-1 RAs and…
- touchPODCAST
MDT and patient perspectives on real-world use of antihyperglycemic therapies to manage T2D and obesity
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient discuss real-world use of antihyperglycemic therapies to…
- touchPODCAST
Perspectives on the mechanism linking obesity with T2D
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the mechanism linking obesity with T2D and share their observations…
- touchPODCAST
Frontline IO for advanced NSCLC: Updates from ASCO and ESMO 2021
touchCONGRESS for touchRESPIRATORY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherapy for…
- touchPODCAST
Frontline IO for advanced NSCLC: Updates from ASCO and ESMO 2021
touchCONGRESS for touchONCOLOGY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherapy for…
- touchPODCAST
Type 2 diabetes experts discuss achieving individualized glycemic targets in patients with T2D
touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Vincent Woo in conversation with Dr Joanna Van. They respond to questions submitted by the HCP…
- touchPODCAST
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 3
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determine…
- touchPODCAST
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 2
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team review a patient profile and describe how they would determine suitability for…
- touchPODCAST
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 1
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the latest data on PD-1/PD-L1 inhibitors and what they mean for patients…
- touchPODCAST
Immunotherapy and evolving approaches for basal cell carcinoma
touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how…
- touchPODCAST
Immunotherapy and evolving approaches for basal cell carcinoma
touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how…
- touchPODCAST
What is the long-term picture for patients with EGFR-mutant NSCLC?
touchMDT for touchONCOLOGY Listen to a medical oncologist and an oncology nurse practitioner discuss how to involve the patient in treatment decisions and the…
- touchPODCAST
What are the implications of adjuvant therapy data on biomarker evaluation?
touchMDT for touchONCOLOGY Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NSCLC. The…
- touchPODCAST
How is the advent of adjuvant therapy in NSCLC changing our approach to surgery?
touchMDT for touchONCOLOGY Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSCLC for…
- touchPODCAST
Patient education, evidence-based treatment and biomarkers in HFrEF
touchPANEL DISCUSSION for touchCARDIO Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement…
- touchPODCAST
Highlights from EHA2021 Virtual 2021: Focus on MDS and AML
touchCONGRESS for touchONCOLOGY Listen to Prof. Uwe Platzbecker (Germany) cover key data presented at EHA2021 Virtual on new and emerging treatments for the…
- touchPODCAST
Perspectives on how novel lipid-lowering therapies may help address current unmet needs
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel…
- touchPODCAST
Perspectives on how novel lipid-lowering therapies may help address current unmet needs
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel…
- touchPODCAST
Perspectives on the latest data for novel lipid-lowering therapies
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean…
- touchPODCAST
Perspectives on the latest data for novel lipid-lowering therapies
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean…
- touchPODCAST
Perspectives on the risk factors for ASCVD and guidelines for dyslipidaemia management
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline…
- touchPODCAST
Perspectives on the risk factors for ASCVD and guidelines for dyslipidaemia management
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and…
- touchPODCAST
HR+/HER2- advanced breast cancer: How do the latest data on CDK4/6 inhibitors inform clinical decision-making?
touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts in breast cancer share their opinion on the latest data which may help guide the use of CDK4/6…
- touchPODCAST
Paving the way for optimal disease control in moderate-to-severe type 2 asthma
touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how…
- touchPODCAST
Paving the way for optimal disease control in moderate-to-severe type 2 asthma
touchPANEL DISCUSSION for touchRESPIRATORY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how…
- touchPODCAST
ACR 2020 – Predictors of Response in Nr‑axSpA Treated with Certolizumab Pegol: The C-axSpAnd Study
touchCONGRESS for touchIMMUNOLOGY Walter Maksymowych (University of Alberta, Alberta, Canada) talks to touchIMMUNOLOGY about the results of the C-axSpAnd Study…
- touchPODCAST
MAb biosimilars for solid tumours: Perspectives for pharmacists
touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss how monoclonal antibody (MAb) biosimilars for solid tumours are developed and…
- touchPODCAST
Highlights from SABCS 2020 Virtual
touchCONGRESS for touchONCOLOGY Listen to key highlights from SABCS Virtual 2020. This touchPODCAST is presented by Prof. Dr Nadia Harbeck. We specifically…
- touchPODCAST
Highlights from ESMO 2020 Virtual
touchCONGRESS for touchONCOLOGY Listen to key highlights from ESMO Virtual 2020. This touchPODCAST is presented by Dr Catherine Kelly. We specifically focus on…